Depletion and replacement of tissue resident macrophages in mice with germ-line deletion of a conserved enhancer in the Csf1r locus.

This study characterizes Fireko mice, a novel model with germ-line deletion of the Csf1r enhancer FIRE that selectively depletes specific tissue-resident macrophages while preserving normal development and organ function, thereby providing a unique platform to investigate macrophage roles in homeostasis and disease.

The Gist

The Big Picture: The "Macrophage" Guardians

Imagine your body is a bustling city. Inside this city, there are specialized security guards called macrophages. These guards live in specific neighborhoods (your organs like the brain, kidneys, heart, and skin). Their job is to clean up trash, fight infections, and keep the neighborhood running smoothly.

To stay on the job, these guards need a specific "radio signal" to know they are needed and to stay alive. This signal is called CSF1R. Think of CSF1R as the radio frequency these guards tune into. If the radio is broken, the guards can't hear the signal, they get confused, and they eventually leave their posts.

The Experiment: Breaking the Radio

The scientists in this study wanted to understand what happens when these guards lose their radio. They created a special type of mouse (called the Fireko mouse) where they deleted a specific piece of DNA called FIRE.

Think of the FIRE element as the instruction manual for building the radio. In these mice, the manual is missing a crucial page.

• The Result: In many parts of the body, the guards (macrophages) never show up or leave early because they can't build their radios.
• The Surprise: Even though the guards are missing from many neighborhoods, the mice are surprisingly healthy! They can grow up, have babies, and live long lives. This tells us that for many organs, the body has a backup plan or doesn't need the guards as much as we thought.

Key Discoveries

1. The "Backup Generator" (CSF2)

The scientists found that while the guards in the bone marrow (the factory where guards are made) lost their main radio, they could sometimes tune into a backup frequency called CSF2.

• Analogy: Imagine a radio station goes off the air, but the listeners can still pick up a signal on a different, less clear frequency. It's not perfect, but it keeps them alive. This explains why the mice aren't completely devoid of immune cells; the backup signal keeps some of them going.

2. The "Vacant Lots" and the "New Tenants"

The researchers noticed that in the Fireko mice, certain neighborhoods (like the brain, kidneys, and heart) were completely empty of their resident guards.

• The Experiment: They took healthy guards from a normal mouse and injected them into the Fireko mice.
• The Result: The healthy guards moved in and filled the empty lots perfectly. They took over the brain (microglia), the kidneys, and the heart.
• The Catch: The new guards in the brain looked a bit different. They were like "new hires" who knew the job but hadn't learned all the local customs yet. They were a bit less "ramified" (less branched out) than the original guards. This suggests that while you can replace the guards, the perfect version of them is hard to recreate once they are gone.

3. The "Kidney Test" (Do we need the guards?)

To see if the missing guards actually mattered, the scientists gave the mice a diet that usually causes kidney damage (like a clogged drain).

• The Expectation: Without the cleaning crew (macrophages), the kidneys should fail miserably.
• The Reality: The Fireko mice (without guards) and the normal mice (with guards) both got kidney damage, and both recovered similarly.
• The Lesson: It turns out that for basic kidney function and even some injuries, the body can cope without these specific resident guards. They are helpful, but not absolutely essential for survival in this context.

4. The "Heterozygous" Mystery (The Half-Broken Radio)

The scientists also looked at mice that had only one broken manual (instead of two).

• The Finding: These mice had a "half-strength" radio signal. As babies, they had fewer guards, but as they grew up, their bodies figured out how to compensate.
• The Lesson: This suggests that the amount of radio signal matters. If you have too little, the guards don't multiply fast enough. But the body is smart; it can sometimes adjust the volume to keep things running.

Why Does This Matter?

This study is like finding a spare key to a very complex house.

1. New Tool for Science: The Fireko mouse is a perfect tool for scientists. Because the "vacant lots" are empty, researchers can easily test what happens when they put specific types of guards back in to see what they actually do.
2. Human Health: Humans have a disease where this same radio system breaks, leading to brain damage. This mouse model helps us understand how to potentially "repopulate" the brain with new, healthy cells to fix the problem.
3. Redundancy: It shows that nature is very redundant. We thought these guards were essential for everything, but the body has many backup systems.

Summary in One Sentence

The scientists broke the "radio manual" in mice to see what happens when their security guards disappear; they found that while many neighborhoods go empty, the mice survive, and scientists can easily move in new guards to study exactly what those guards do, offering hope for treating human diseases where these guards fail.

Technical Summary

1. Problem Statement

The Mononuclear Phagocyte System (MPS) relies on the Macrophage Colony-Stimulating Factor Receptor (CSF1R) for proliferation, differentiation, and survival. Previous models of CSF1R deficiency (e.g., Csf1r^-/- or Csf1^-/-) result in severe systemic phenotypes, including osteopetrosis, growth retardation, and early perinatal lethality, making it difficult to study the specific roles of tissue-resident macrophages in adult homeostasis and pathology.

While a hypomorphic mutation deleting the Fms-intronic regulatory element (FIRE) was previously described (Fireko mice), its behavior on the C57BL/6J background was lethal due to hydrocephalus. Furthermore, the molecular mechanisms governing the selective loss of macrophages in specific tissues (e.g., kidney, heart, microglia) versus their retention in others (e.g., liver, spleen) remained unclear. The study aimed to:

• Establish a viable, congenic Fireko mouse model to dissect tissue-specific macrophage functions.
• Determine the mechanisms of selective macrophage depletion and the role of CSF2 (GM-CSF) in compensating for CSF1R loss.
• Investigate the functional consequences of macrophage absence in organs like the kidney and heart.
• Test the feasibility of repopulating vacant macrophage niches via bone marrow adoptive transfer.

2. Methodology

• Mouse Models:
  • Fireko Mice: Generated by deleting a 300bp conserved enhancer (FIRE) in the Csf1r locus using CRISPR-Cas9. The allele was backcrossed to C57BL/6J and crossed with a Csf1r-EGFP reporter line. To overcome perinatal lethality/hydrocephalus, the line was maintained on a mixed background (retaining non-C57BL/6J sequences) or crossed with CBA/J mice.
  • AP1 Mutant Mice: A specific AP1 motif within the FIRE enhancer was mutated via CRISPR-Cas9 to assess its contribution to transcription kinetics.
  • Chimeric Models: Fireko mice received intraperitoneal (IP) adoptive transfer of wild-type (WT) bone marrow cells (expressing Csf1r-FusionRed) at weaning (3 weeks) to assess niche repopulation.
• In Vivo Interventions:
  • CSF1 Challenge: Administration of CSF1-Fc fusion protein to assess systemic responsiveness.
  • Inflammation Models: Thioglycolate-induced peritonitis and Adenine-induced chronic kidney disease (CKD).
  • Cardiac Assessment: Echocardiography (Vevo 2100) to measure cardiac function.
• In Vitro Assays:
  • Bone marrow cultures with CSF1, CSF2 (GM-CSF), and RANKL to assess differentiation into macrophages and osteoclasts.
  • Receptor resynthesis assays following ligand removal or PMA/LPS stimulation.
• Analytical Techniques:
  • Flow Cytometry: To quantify monocyte/macrophage subsets (Ly6C^hi/lo, CD115, F4/80) in blood, bone marrow, and tissues.
  • Whole Mount Imaging: Using Csf1r-EGFP and Csf1r-FusionRed reporters to visualize tissue architecture and macrophage distribution in organs (lung, testis, liver, brain).
  • Histology & IHC: H&E, PAS, Sirius Red, and immunostaining (F4/80, IBA1, CD169, CD206) for pathological assessment.
  • qRT-PCR: To measure mRNA levels of Csf1r and tissue-specific markers.

3. Key Contributions

• Viable Model of Selective Deficiency: The study successfully established a congenic Fireko mouse line that survives to adulthood, lacking specific tissue-resident macrophage populations (microglia, kidney, heart, peritoneal) while retaining others (liver Kupffer cells, splenic marginal zone metallophils).
• Mechanism of Selective Loss: Demonstrated that the loss of the FIRE enhancer renders progenitors unresponsive to CSF1. However, CSF2 (GM-CSF) can partially induce Csf1r expression in bone marrow progenitors, explaining why some tissues (like the liver) retain macrophages via local CSF2 signaling, while others (like the kidney) do not.
• Haploinsufficiency: Showed that heterozygous Fireko mice exhibit delayed postnatal expansion of macrophages in specific tissues (brain, kidney), indicating that receptor density is a limiting factor for CSF1 responsiveness.
• Functional Redundancy: Provided evidence that the absence of resident macrophages in the kidney and heart does not compromise basal organ function or development, challenging the notion that these cells are strictly essential for homeostasis in steady-state conditions.
• Niche Repopulation: Demonstrated that vacant macrophage niches in Fireko mice can be selectively repopulated by donor-derived cells from WT bone marrow, whereas circulating monocytes are not replaced, proving the existence of a direct progenitor-to-tissue-resident pathway.

4. Key Results

• Phenotype: Fireko mice lack CSF1R expression in bone marrow progenitors and classical monocytes. They are unresponsive to CSF1-Fc in vivo (no monocytosis or organomegaly).
• Tissue Specificity:
  • Depleted: Microglia, kidney (F4/80^hi), heart, peritoneal cavity, testis (peritubular), lung (interstitial), and epidermis (Langerhans cells in ear).
  • Retained: Liver (Kupffer cells), spleen (marginal zone), and bone (osteoclasts are present, unlike in Csf1r^-/-).
• CSF2 Compensation: In vitro, CSF2 can drive Csf1r expression in Fireko progenitors (at 10-15% of WT levels) and support macrophage differentiation, but it fails to rescue osteoclast generation.
• AP1 Motif Function: Mutation of the conserved AP1 site within FIRE reduced the rate of Csf1r re-synthesis after ligand removal but did not cause the complete tissue-specific depletion seen in full FIRE deletion, suggesting FIRE regulates transcription kinetics rather than being the sole on/off switch.
• Pathology:
  • Kidney: Despite lacking resident macrophages, Fireko mice showed normal basal kidney function. In an adenine-induced CKD model, macrophage recruitment occurred in both WT and Fireko mice, and histological injury was similar, though male Fireko mice had slightly elevated urea/creatinine.
  • Heart: Echocardiography revealed no functional deficits in Fireko mice, contradicting previous findings that macrophage depletion causes rapid cardiac dysfunction.
• Adoptive Transfer:
  • IP transfer of WT bone marrow into Fireko mice at weaning led to the selective repopulation of vacant niches (microglia, kidney, peritoneum) by donor cells.
  • Microglia: Donor-derived cells repopulated the brain but lacked the extensive ramification and homeostatic markers (P2RY12, TMEM119) of native microglia, suggesting a distinct maturation state.
  • Specificity: Donor cells did not contribute to the blood monocyte pool or replace resident macrophages in WT mice, confirming the specificity of the niche vacancy.

5. Significance

• Novel Platform: The Fireko mouse provides a unique tool to study the specific functions of tissue-resident macrophages without the confounding systemic lethality of global Csf1r knockout.
• Developmental Insights: The findings suggest that tissue-resident macrophages in certain organs (kidney, heart) are not strictly required for embryonic development or basal homeostasis, but may be critical for mitigating injury or age-related pathology.
• Therapeutic Implications: The successful repopulation of the microglial niche by bone marrow-derived cells offers a potential therapeutic avenue for CSF1R-related leukoencephalopathies in humans, although the functional maturity of the repopulated cells requires further optimization.
• Transcriptional Regulation: The study elucidates the complex interplay between enhancer elements (FIRE/AP1), ligand availability (CSF1 vs. CSF2), and receptor kinetics in determining macrophage lineage commitment and tissue distribution.

In conclusion, this paper redefines the understanding of CSF1R biology, highlighting the redundancy in macrophage development and the critical importance of tissue-specific microenvironments in maintaining the mononuclear phagocyte system.